A
Last Price
52 Week Range
SGD0.03 - SGD0.20
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | SGD203.59M |
EV | SGD178.63M |
Shares Outstanding | 1.02B |
Beta | 1.37 |
Industry | - |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E 2026E | - |
P/Revenue 2026E | - |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2026E | - |
Net Profit Margin 2026E | - |
ROE 2026E | - |
ROCE 2025 | 2.27% |
DPS 2026E | - |
Payout Ratio 2026E | - |
Div. Yield 2026E | - |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
Aoxin Q & M Dental Group Limited
1D4
Sector
Industry
CEO
Bai, Yi
Employees
Website
www.aoxinqm.com.sgIPO Date
Headquarters
9 Raffles Place, #26-01, Republic Plaza, Singapore 048619, Singapore
The last closing price of Aoxin Q & M Dental Group (1D4) is SGD0.20, reflecting a +5.29% change from the prior session. Last updated: March 7, 2026 at 7:56 PM Eastern Time
Over the last year, Aoxin Q & M Dental Group (1D4) has established a 52-week price range between a high of SGD0.21 and a low of SGD0.03. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 7:56 PM Eastern Time
Aoxin Q & M Dental Group (1D4) is considered a medium volatility stock. It has a beta of 1.37, which means it typically moves 1.37 times as much as the broader market. Over the past 52 weeks, 1D4 has traded within a SGD0.03 – SGD0.21 range. Last updated: March 7, 2026 at 7:56 PM Eastern Time
The current Aoxin Q & M Dental Group (1D4) market capitalization is approximately SGD203.59M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Aoxin Q & M Dental Group's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 7:56 PM Eastern Time
In the most recently reported quarter, Aoxin Q & M Dental Group (1D4) generated CN¥43.63M in revenue, representing a -12.37% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: April 2, 2026 at 1:45 AM Eastern Time
In the most recently reported fiscal year, Aoxin Q & M Dental Group (1D4) generated net income of CN¥6.97M, compared with CN¥-1.76M in the prior fiscal year, representing a -495.97% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: April 2, 2026 at 1:45 AM Eastern Time
According to its latest quarterly filing, Aoxin Q & M Dental Group (1D4) reported EBITDA of CN¥4.05M, representing a -39.37% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: April 2, 2026 at 1:45 AM Eastern Time
As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.04x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: April 2, 2026 at 1:45 AM Eastern Time
Based on the latest available data, Aoxin Q & M Dental Group (1D4) is currently trading at a last twelve months (LTM) P/E ratio of 15.47x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: April 2, 2026 at 1:45 AM Eastern Time
In the most recently reported quarter, Aoxin Q & M Dental Group (1D4) revenue was CN¥43.63M. Earnings per share (EPS) for the quarter were CN¥0.00. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: April 2, 2026 at 1:45 AM Eastern Time
Aoxin Q & M Dental Group (1D4) does not currently pay a dividend. Over the last twelve months (LTM), the company paid SGD0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: April 2, 2026 at 1:45 AM Eastern Time
Based on the latest available analyst coverage, Aoxin Q & M Dental Group (1D4) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: April 2, 2026 at 1:45 AM Eastern Time
Like other publicly traded stocks, Aoxin Q & M Dental Group (1D4) shares are bought and sold on stock exchanges such as Catalist and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Aoxin Q & M Dental Group (1D4) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 1D4 to your watchlist.
Aoxin Q & M Dental Group trades under the ticker symbol 1D4 on the Catalist stock exchange. The ticker 1D4 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
Aoxin Q & M Dental Group (1D4) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Aoxin Q & M Dental Group (1D4) stock peers based on overlapping products, services, and competitive dynamics:AsiaMedic (505)Medeze Group Public (MEDEZE)Dental Corporation Public (D)Harbin Pharmaceutical Group (600664)Clearbridge Health (1H3)Concord Medical Services Holdings (CCM)LDC Dental Public (LDC)PT Diagnos Laboratorium Utama Tbk (DGNS)King International Investment (928)China Biotech Services Holdings (8037) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Aoxin Q & M Dental Group.
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers